SuperworthGT Biopharma shares outstanding GTBP
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 1.6M
- On a year earlier
- +1300.6%
- more shares
GT Biopharma had 1.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1300.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 515.9K | +472% |
| FY2024 | 90.2K | +63% |
| FY2023 | 55.2K | +28% |
| FY2022 | 43.1K | +591% |
| FY2020 | 6.2K | +17% |
| FY2019 | 5.3K | +35% |
| FY2018 | 4K | +1% |
| FY2017 | 3.9K | +50225% |
| FY2016 | 8 | +1155% |
| FY2014 | 1 | +3% |
| FY2013 | 1 | +20% |
| FY2012 | 0 | +87% |
| FY2011 | 0 | +86% |
| FY2010 | 0 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.6M | +1301% | |
| Q1 FY26 | 1.2M | +1191% | |
| Q4 FY25 | 515.9K | +472% | |
| Q3 FY25 | 157.6K | +76% | |
| Q2 FY25 | 110.9K | +62% | |
| Q1 FY25 | 93.8K | +70% | |
| Q4 FY24 | 90.2K | +63% | |
| Q3 FY24 | 89.4K | +63% | |
| Q2 FY24 | 68.5K | +28% | |
| Q1 FY24 | 55.2K | +27% | |
| Q4 FY23 | 55.2K | +28% | |
| Q3 FY23 | 54.7K | +31% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on GT Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.